Specific gene expression profiles distinguish among functional allelic variants of the mouse Pthlh gene in transfected human cancer cells

Oncogene

Volumn 25, Issue 32, 2006, Pages 4501-4504

  Gianni Barrera, R ^a   Gariboldi, M ^a,b   De Cecco, L ^a,b   Manenti, G ^a   Dragani, T A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Cancer modifiers; NCI H520; Parathyroid hormone like hormone; Parathyroid hormone related protein; PTHrP

Indexed keywords

COMPLEMENTARY DNA; PARATHYROID HORMONE RELATED PROTEIN;

ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ANXA1 GENE; ARTICLE; CCL2 GENE; CELL MIGRATION; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DNA MODIFICATION; FN1 GENE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; GENETIC VARIABILITY; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PTHLH GENE; SKIN CARCINOGENESIS; TFF3 GENE;

ALLELES; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION PROFILING; HUMANS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARATHYROID HORMONE-RELATED PROTEIN; SKIN NEOPLASMS; TRANSFECTION; VARIATION (GENETICS);

EID: 33746508998     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209478     Document Type: Article

References (20)

1. Benelli R, Peissel B, Manenti G, Gariboldi M, Vanzetto C, Albini A et al. (2003). Oncogene 22: 7711-7715.
2. Cambien B, Pomeranz M, Millet MA, Rossi B, Schmid-Alliana A. (2001). Blood 97: 359-366.
3. De Cecco L, Marchionni L, Gariboldi M, Reid JF, Lagonigro MS, Caramuta S et al. (2004). Oncogene 23: 8171-8183.
4. Deans C, Wigmore S, Paterson-Brown S, Black J, Ross J, Fearon KC. (2005). Cancer 103: 1810-1818.
5. Dragani TA. (2003). Cancer Res 63: 3011-3018.
6. Duxbury MS, Matros E, Clancy T, Bailey G, Doff M, Zinner MJ et al. (2005). Ann Surg 241: 491-496.
7. Dysvik B, Jonassen I. (2001). Bioinformatics 17: 369-370.
8. Funk JL. (2001). Int J Immunopharmaco 1: 1101-1121.
9. Hiraki A, Ueoka H, Bessho A, Segawa Y, Takigawa N, Kiura K et al. (2002). Cancer 95: 1706-1713.
10. Hoffmann W, Jagla W, Wiede A. (2001). Histol Histopathol 16: 319-334.
11. Leeb SN, Vogl D, Grossmann J, Falk W, Scholmerich J, Rogler G et al. (2004). Am J Gastroenterol 99: 335-340.
12. Manenti G, Peissel B, Gariboldi M, Falvella FS, Zaffaroni D, Allaria B et al. (2000). Oncogene 19: 5324-5328.
13. Maus UA, Waelsch K, Kuziel WA, Delbeck T, Mack M, Blackwell TS et al. (2003). J Immunol 170: 3273-3278.
14. Nagase H, Mao JH, de Koning JP, Minami T, Balmain A. (2001). Cancer Res 61: 1305-1308.
15. Oertel M, Graness A, Thim L, Buhling F, Kalbacher H, Hoffmann W. (2001). Am J RespCell Mol 25: 418-424.
16. Parente L, Solito E. (2004). Inflamm Res 53: 125-132.
17. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P et al. (2000). Nat Genet 24: 227-235.
18. Strewler GJ. (2000). N Engl J Med 342: 177-185.
19. Yio X, Zhang JY, Babyatsky M, Chen A, Lin J, Fan QX et al. (2005). Clin Exp Metastasis 22: 157-165.
20. Zhang ZW, Newcomb PV, Moorghen M, Gupta J, Feakins R, Savage P et al. (2004). Cancer Causes Control 15: 211-218.